A Patient-Centric Platform Trial for Precision Oncology

Study on Cancer Patient Data Collection for Treatment Information

Recruiting
All
Phase N/A
10000 participants needed
1 Location

Study Overview

XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and associated supportive care will be collected for analysis.

Study Details

XCELSIOR is patient-centric study for the registration of cancer patients, operations of a virtual tumor board, insight capture in clinical decision making, and collection of longitudinal, observational data in a cancer registry. Patient intake into XCELSIOR will occur through the Cancer Commons Web portal. This includes consent to participate in the data registry, including the collection and review of medical information by a Virtual Tumor Board, generation of patient-specific treatment options with supporting rationale, access to treatment access support services, and inclusion into a registry study that includes safety and efficacy outcomes tracking. Patients will be treated and tracked in their original treatment setting and the data generated will form part of a systematic framework combining expert judgment with artificial intelligence to maximize information gain and improve treatment option set development for individual cancer patients.

Eligibility Criteria

You may be eligible for this study if you meet the following criteria:

  • Conditions: Oncology
  • Gender: All

Inclusion Criteria:
  • Both male and female patients with known or suspected recalcitrant or advanced cancer are eligible to enroll through the Cancer Commons Website
  • Patients with any performance status, comorbidity or disease severity are eligible
  • Patients or their legally-authorized representative must be willing and able to provide written, informed consent (and assent, if applicable)
Exclusion Criteria:
  • Patients must be a resident of or receiving care within the United States or US territories.

Updated on 03 Dec 2024. Study ID: NCT03793088

This study investigates a registry platform for cancer patients, focusing on collecting data about their treatments, decisions, and outcomes. The aim is to understand the effectiveness and safety of anti-cancer therapies and supportive care. An observational study is a type of research study where data is collected by observing participants receiving routine care, without changing their treatment, which may focus on people using specific medications or having certain conditions to better understand how treatments work.

Participants will consent to share their medical information, which will be reviewed by a virtual tumor board. This board will help generate personalized treatment options. The study will track patients in their usual treatment settings, collecting data on safety and efficacy outcomes. This information will be used alongside expert judgment and artificial intelligence to improve treatment options.

  • Who can participate: Adults with known or suspected advanced cancer can participate. Eligible participants include both males and females, regardless of performance status or disease severity, who can provide informed consent and reside in the United States or its territories.
  • Study details: Participants will share their medical data for review to create personalized treatment plans. The study tracks treatment outcomes in usual care settings to gather data on safety and efficacy.

Find a study site near you

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
US Only: Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language